This lawsuit alleges that Group Health Cooperative unlawfully placed quantitative visit limits on mental health services that would be covered for a five year old plan beneficiary, in violation of the Mental Health Parity and Addiction Equity Act.
Invokana, Invokamet, Jardiance, Xigduo XR, Farxiga, and Glyxambi are drugs used to treat Type 2 diabetes. An investigation is now looking into possible connections between these drugs and a serious condition called ketoacidosis.
This mass tort investigation alleges that the diabetes drug Onglyza can raise the risk of pancreatic cancer in patients and cause heart failure and death. Onglyza is made by AstraZeneca and has been approved by the FDA for the treatment of Type 2 diabetes.